arrow
C

Christian Kuffer

Novartis
H指数:11
被引数:819

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/− lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study

ctDNA动力学证明了tafasitamab + R-CHOP +/- lenalidomide的快速治疗反应,并能预测弥漫性大B细胞淋巴瘤的结局:First-MIND 1b期研究结果

Leukemia
IF13.4
2025-10-270
OA
Tafasitamab for patients with relapsed or refractory diffuse large B-cell lymphoma: final 5-year efficacy and safety findings in the phase II L-MIND study
2023-08-3113
OAAI